HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Rating of "Moderate Buy" by Analysts

Key Points

• HealthEquity has a “Moderate Buy” consensus rating from 13 analysts, with 11 buy ratings, one hold and one sell. The average 12-month price target is $110.93, above the reported opening price of $100.61.
• The company exceeded quarterly expectations, reporting $1.24 in EPS versus the $1.11 consensus estimate and $354.64 million in revenue, up 7.2% year over year.
• Insiders sold 17,905 shares worth approximately $1.65 million over the past 90 days under pre-arranged Rule 10b5-1 plans, while institutional investors own 99.55% of the stock.

Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have received a consensus rating of "Moderate Buy" from the thirteen brokerages that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and eleven have given a buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $110.9286.

HQY has been the subject of several research reports. BMO Capital Markets upgraded shares of HealthEquity from a "market perform" rating to an "outperform" rating and increased their price target for the stock from $85.00 to $105.00 in a research note on Thursday, April 9th. Citizens Jmp boosted their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the stock a "market outperform" rating in a research note on Monday, June 1st. Citigroup restated a "market outperform" rating on shares of HealthEquity in a report on Monday, June 1st. KeyCorp reaffirmed an "overweight" rating on shares of HealthEquity in a research note on Tuesday, May 26th. Finally, Barrington Research reiterated an "outperform" rating and set a $110.00 target price on shares of HealthEquity in a report on Friday, May 22nd.

Insider Buying and Selling

In related news, EVP Delano Ladd sold 7,500 shares of the firm's stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the transaction, the executive vice president owned 91,141 shares of the company's stock, valued at $8,202,690. This trade represents a 7.60% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director owned 19,733 shares of the company's stock, valued at $1,775,970. The trade was a 11.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 17,905 shares of company stock worth $1,651,280 in the last 90 days. Insiders own 1.60% of the company's stock.

Hedge Funds Weigh In On HealthEquity

A number of hedge funds have recently bought and sold shares of the company. Acumen Wealth Advisors LLC bought a new stake in HealthEquity during the 4th quarter valued at about $27,000. Aster Capital Management DIFC Ltd bought a new position in shares of HealthEquity in the fourth quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company's stock worth $28,000 after buying an additional 293 shares in the last quarter. Leonteq Securities AG grew its holdings in shares of HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company's stock valued at $32,000 after buying an additional 235 shares during the last quarter. Finally, Axiom Investment Management LLC purchased a new stake in shares of HealthEquity during the first quarter valued at approximately $33,000. Institutional investors own 99.55% of the company's stock.

HealthEquity Stock Performance

Shares of HQY opened at $100.61 on Monday. The firm's 50-day moving average price is $91.74 and its 200-day moving average price is $85.13. The firm has a market capitalization of $8.41 billion, a price-to-earnings ratio of 37.68, a PEG ratio of 1.69 and a beta of 0.21. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. HealthEquity has a 1-year low of $72.76 and a 1-year high of $105.96.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. HealthEquity's revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Sell-side analysts anticipate that HealthEquity will post 3.92 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.